Remove Arrhythmia Remove Sudden Cardiac Death Remove Tachycardia
article thumbnail

Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors - a systematic review and meta-analysis

Open Heart

Background Ventricular arrhythmias (VAs) frequently occur in the acute phase of myocarditis. Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern, and limited data have been published to guide clinical management of these patients. to 0.53, p=0.13).

article thumbnail

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of?>?80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)

Cardiovascular Diabetology

Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective effects via multiple mechanisms that may also contribute to decrease arrhythmias risk.

article thumbnail

The Irate Stellate Ganglion: IL-6 in Neuroinflammation-induced Ventricular Arrhythmias

HeartRhythm

Sympathetic nervous system hyperactivity plays a major role in the pathogenesis of ventricular arrhythmias following myocardial infarction (MI).1,2 1,2 The stellate ganglia are an important nexus point for sympathetic innervation to the heart.3

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Recent advancements in catheter ablation for structural ventricular tachycardia (VT), such as high-density mapping and cardiac imaging-based detection of target areas, have significantly improved the efficacy of ablation procedures.

article thumbnail

PO-01-146 SUCCESSFUL CATHETER ABLATION OF VENTRICULAR TACHYCARDIA BEFORE TRANSCATHETER PULMONARY VALVE IMPLANTATION IN THE PATIENT WITH REPAIRED DOUBLE OUTLET RIGHT VENTRICLE

HeartRhythm

Patients with adult congenital heart disease are at risk for ventricular arrhythmias (VAs) or sudden cardiac death.

article thumbnail

Application and Validation of Phenotype-Enhanced Variant Classification in East Asian Patients with Catecholaminergic Polymorphic Ventricular Tachycardia

HeartRhythm

Catecholaminergic polymorphic ventricular tachycardia (CPVT) has been identified as a notable cause of sudden cardiac death in children and young adults.1 Catecholaminergic polymorphic ventricular tachycardia (CPVT) has been identified as a notable cause of sudden cardiac death in children and young adults.1

article thumbnail

PO-02-168 EVALUATION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ALGORITHM ACCURACY IN DIFFERENTIATING SUPRAVENTRICULAR TACHYCARDIA FROM ATRIAL FIBRILLATION.

HeartRhythm

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.